Loading...

Rituximab Biosimilar Prevents Poor Outcomes of Microscopic Polyangiitis and Granulomatosis with Polyangiitis as Effectively as Rituximab Originator

PURPOSE: There has been no extensive study to compare the efficacy between rituximab originator (Mabthera®) and its biosimilar (Truxima®) for microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA). Here, we investigated the clinical effects of rituximab on poor outcomes of MPA and...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Yonsei Med J
Main Authors: Kwon, Hyeok Chan, Kim, Minyoung Kevin, Song, Jason Jungsik, Park, Yong-Beom, Lee, Sang-Won
Format: Artigo
Sprog:Inglês
Udgivet: Yonsei University College of Medicine 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7393299/
https://ncbi.nlm.nih.gov/pubmed/32734735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2020.61.8.712
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!